These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 29272035)
61. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome. Sederholm BH Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678 [TBL] [Abstract][Full Text] [Related]
62. Intravenous immunoglobulin for treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in France: are daily practices in accordance with guidelines? Rosier C; Graveline N; Lacour A; Antoine JC; Camdessanché JP Eur J Neurol; 2019 Apr; 26(4):575-580. PubMed ID: 30326184 [TBL] [Abstract][Full Text] [Related]
63. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases. Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182 [TBL] [Abstract][Full Text] [Related]
64. Long-term evolution of anti-ganglioside antibody levels in patient with chronic dysimmune neuropathy under IVIg therapy. Matà S; Borsini W; Caldini A; De Scisciolo G; Piacentini S; Taiuti R J Neuroimmunol; 2006 Dec; 181(1-2):141-4. PubMed ID: 17023053 [TBL] [Abstract][Full Text] [Related]
65. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy. Gorson KC; Amato AA; Ropper AH Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250 [TBL] [Abstract][Full Text] [Related]
66. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years. Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193 [TBL] [Abstract][Full Text] [Related]
67. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies]. Kusunoki S Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820 [TBL] [Abstract][Full Text] [Related]
68. MMN: from immunological cross-talk to conduction block. Harschnitz O; Jongbloed BA; Franssen H; Straver DC; van der Pol WL; van den Berg LH J Clin Immunol; 2014 Jul; 34 Suppl 1(Suppl 1):S112-9. PubMed ID: 24728842 [TBL] [Abstract][Full Text] [Related]
70. Sonographic Multifocal Cranial Nerve Enlargement in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy. Oka Y; Tsukita K; Tsuzaki K; Takamatsu N; Hamano T Intern Med; 2021 Sep; 60(17):2867-2871. PubMed ID: 33746164 [TBL] [Abstract][Full Text] [Related]
71. Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies. Gallia F; Balducci C; Nobile-Orazio E J Peripher Nerv Syst; 2016 Jun; 21(2):82-4. PubMed ID: 26817673 [TBL] [Abstract][Full Text] [Related]
72. [Autoimmune neuropathies: diagnosis, treatment, and recent topics]. Ueda M; Kusunoki S Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658 [TBL] [Abstract][Full Text] [Related]
73. Normalization of sonographical multifocal nerve enlargements in a MADSAM patient following a good clinical response to intravenous immunoglobulin. Tanaka K; Ota N; Harada Y; Wada I; Suenaga T Neuromuscul Disord; 2016 Sep; 26(9):619-23. PubMed ID: 27460345 [TBL] [Abstract][Full Text] [Related]